Why it was recalled
Presence of particulate matter: potential presence of metal particulates in the product.
Product description
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Lot numbers, UPCs & expiration codes
Lot #: Z014503, Exp 11/15/2027
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0241-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Dec 12, 2025
- FDA report date
- Dec 31, 2025
- Quantity
- 3 - single dose kits
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Merck Sharp & Dohme LLC
Original FDA data
Every field from FDA enforcement report D-0241-2026, exactly as published.
Show all FDA fields
- City
- Wilson
- State
- NC
- Status
- Ongoing
- Country
- United States
- Event ID
- 98113
- Address
- 4633 Merck Rd W
- Code information
- Lot #: Z014503, Exp 11/15/2027
- Postal code
- 27893-9613
- Report date
- Dec 31, 2025
- Product type
- Drugs
- Recall number
- D-0241-2026
- Classification
- Class II
- Recalling firm
- Merck Sharp & Dohme LLC
- Product quantity
- 3 - single dose kits
- Reason for recall
- Presence of particulate matter: potential presence of metal particulates in the product.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Dec 12, 2025
- Initial firm notification
- Letter
- Center classification date
- Dec 23, 2025